Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_95714119

Cancer trials underrepresent minorities and elderly, Mayo Clinic says

September 26, 2017
Manufacturing and Production, Research and Development clinical trials, pharma, pharmaceutical

New research conducted by the Mayo Clinic in Minnesota has found participant groups for clinical trials in cancer underrepresent ethnic …

News
image_credit_interpol

Pangea X: the largest coordinated operation against counterfeit drugs

September 26, 2017
Manufacturing and Production, Sales and Marketing Europol, FDA, biotech, drugs, interpol, pharma, pharmaceutical

Operation Pangea X represents an anniversary, of sorts – as it stands as the 10th year of operations by Interpol …

News
pharmafocus_october__cover_2017

The October 2017 issue of Pharmafocus is now live!

September 26, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, EMA, Pharmafocus

The October edition of Pharmafocus is now live! You can read it here.

News

Pfizer sets up its own biotech to develop rejected drugs

September 26, 2017
Manufacturing and Production, Sales and Marketing Pfizer, SpringWorks Therapeutics, biotech, drugs, pharma, pharmaceutical

Pfizer has moved to set up an entirely independent company to develop four of its own clinical-stage drug candidates. The …

News
shutterstock_57369385

Refining the system: Improving patients’ access to medicine

September 25, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NCIE, drug access, eams, market access, pharma, pharmaceuticals

The MHRA and NICE have been slowly improving the ways that the UK’s patients access medicines, but now Brexit threatens …

Feature
allergan

Allergan posts disappointing data in NASH

September 25, 2017
Research and Development, Sales and Marketing Allergan, biotech, drugs, nash, pharma, pharmaceutical

It was only last year that Allergan decided to cough up $1.7 billion to acquire Tobira Therapeutics, with the main …

News

Sanofi’s arthritis treatment Kevzara secures NICE recommendation

September 25, 2017
Sales and Marketing Kevzara, NICE, Sanofi, pharma, pharmaceutical, rheumatoid arthritis, sarilumab

Sanofi, along with its speciality care global business unit Sanofi Genzyme, are celebrating the news that NICE has passed its …

News
aedes_aegypti_during_blood_meal

‘Super malaria’ sweeps South East Asia

September 25, 2017
Medical Communications, Sales and Marketing biotech, drug resistance, drug-resistance, drugs, malaria, pharma, pharmaceutical

There has long been concern over cases of drug-resistant malaria emerging in Asia and now it has been revealed that …

News
shutterstock_235920349

Indivior reaches settlement with Mylan over patent dispute

September 25, 2017
Sales and Marketing Mylan, indivior, patent, pharma, pharmaceutical, suboxone

Indivior has ended a patent dispute with Mylan concerning its heroin addiction therapy Suboxone (buprenorphine and naloxone) sublingual film by …

News
jj_2johnson_and_johnson

FDA rejects J&J’s treatment for rheumatoid arthritis

September 25, 2017
Sales and Marketing Johnson & Johnson, biotech, drugs, pharma, pharmaceutical, sirukumab

Perhaps unsurprisingly, after the FDA’s advisory committee had voted 12-1 against approval of Johnson & Johnson’s drug, the FDA returned …

News
alnylam

Alnylam soars on likely first RNAi treatment approval

September 22, 2017
Medical Communications, Research and Development Alynylam, Sanofi, biotech, drugs, patisran, pharma, pharmaceutical

Alnylam has been plugging away in the RNAi-based treatment area for 15 years and, finally, has something to show for …

News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

September 22, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

It’s been a great week for drug research and access, with the first-ever FDA approval of a biosimilar in cancer …

News
fda_building_web

19 deaths from liver drug causes Intercept shares to tumble

September 22, 2017
Medical Communications, Sales and Marketing Intercept Pharmaceuticals, Ocliva, biotech, drugs, pharma, pharmaceutical

Intercept Pharmaceuticals had sparked major concerns over its drug, Ocaliva, after it revealed that 10 people had died as a …

News

NICE recommends Bayer’s Eylea for myopic chorodial neovascularisation

September 22, 2017
Medical Communications, Sales and Marketing Bayer, Eylea, NICE, pharma, pharmaceutical

Bayer has revealed that UK drug regulator NICE has given its final recommendation on blockbuster eye drug Eylea (aflibercept solution …

News

New therapy offers triple threat to HIV virus

September 22, 2017
Medical Communications, Research and Development HIV, Sanofi, biotech, drugs, pharma, pharmaceutical

Sanofi and the National Institutes of Health (NIH) have combined to create a potential HIV therapy that was shown to …

News
crack_cocaine

Weight loss drugs could be used to treat cocaine addiction

September 21, 2017
Research and Development addiction, cocaine, cocaine addiction, lorcaserin, pharma, pharmaceutical

Researchers at the Boston Medical Center are investigating the potential of utilising weight loss drugs in the treatment of cocaine …

News
andrew_witty_gsk

Witty, Ex-CEO of GSK, keeps busy with two new roles in two days

September 21, 2017
Medical Communications : Pharma, Andrew Witty, GSK, biotech, drugs, pharma, pharmaceutical

It was always unlikely that Andrew Witty, former CEO of GSK, would take his ‘retirement’ from the company literally, but …

News
gp_commissioning_patient

Report finds variation in quality of care in GP practices across England

September 21, 2017
Medical Communications : Pharma, England, GP, NHS, biotech, drugs, pharma, pharmaceutical

Depending on your interpretation of results from the Care Quality Commission’s (CQC) recent report on the standard of care provided …

News

Merck and Pfizer’s joint skin cancer drug gets EU approval

September 21, 2017
Sales and Marketing Bavencio, Cancer, Merck, Pfizer, merkel cell carcinoma, pharma, pharmaceutical, skin canceer

Merck KGaA and Pfizer have announced that European authorisation of their jointly developed drug Bavencio (avelumab) as a monotherapy in …

News
Bayer image

Bayer pulls plug on sterilisation device after numerous complaints

September 21, 2017
Sales and Marketing Bayer, Essure, biotech, drugs, pharma, pharmaceutical

Bayer has stopped the commercial sale of a sterilisation device in all countries, except the US, after reports that it …

News
The Gateway to Local Adoption Series

Latest content

Five Facts about the menopause

March 6, 2026

Zello Appoints Kevin Bailey as Group Chief Medical Officer

March 6, 2026

BioDuro establishes joint manufacturing venture with Cenra

March 6, 2026

Symbiosis appoints Joanne Anderson as Chief Commercial Officer

March 6, 2026

Secarna Pharmaceuticals and Curie.Bio expand existing partnership

March 6, 2026